MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Emergent Biosolutions Company Profile (NYSE:EBS)

Consensus Ratings for Emergent Biosolutions (NYSE:EBS) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $34.50 (5.63% upside)

Analysts' Ratings History for Emergent Biosolutions (NYSE:EBS)
Show:
DateFirmActionRatingPrice TargetActions
3/6/2015Summer StreetReiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015JPMorgan Chase & Co.Boost Price TargetOverweight$32.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014Summer StreetInitiated CoverageBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2013HSBCUpgradeNeutral -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013Deutsche BankBoost Price TargetHold€23.90 -> €24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha